TINJAUAN PUSTAKA EVALUASI FARMAKOVIGILANS OBAT ANTIDIABETES ORAL PADA PASIEN RAWAT JALAN DIABETES MELITUS TIPE II

  • Nena Vauziah Sary Universitas Singaperbangsa Karawang
Keywords: Farmakovigilans, Diabetes Mellitus, ADR

Abstract

Diabetes Mellitus can be treat with pharmacological therapy in the form of oral drug administration. This step has side effects in the form of adverse drug reactions. ADR adapts various factors that can influence the patient to adverse reactions.The purpose of this study was to determine the percentage of incidence of ADR in outpatients with type II diabetes mellitus. This research method is a literature study method searched through PubMed, Google Scholar, and Research Gate using the keywords pharmacovigilance, diabetes mellitus, and adverse drug reaction (ADR). The criteria for articles used were publish in the last 10 years, namely 2012 to 2022, the journal has a title and content that is in accordance with the research objectives. The occurrence of ADR was influence by the gender and type of drug taken. This is in accordance with the research. Oral hypoglycemic drugs that were suspect to be the cause of the onset of ADRs are metformin causing nausea effects and acarbose causing flatulence effects. The use of the Naranjo algorithm is indispensable for assessing the severity of the ADR.

Keywords: Farmakovigilans., Diabetes Melitus, ADR

Downloads

Download data is not yet available.

References

Fitriyani dan Supadmi, W., 2012, Evaluasi Adverse Drug Reaction Antidiabetes Berlandaskan Algoritma Naranjo Di Bangsal Rawat Inap Rs Pku Muhammadiyah Yogyakarta Periode Desember 2011- Januari 2012, Jurnal Ilmiah Kefarmasian, Vol. 2, No. 2, 2012 : 205 – 213.
Franklin JM, Schneeweiss S, Polinski JM, Rassen JA. Plasmode simulation for the evaluation of pharmacoepidemiologic methods in complex healthcare databases. Comput Stat Data Anal. 2014;72:219–26.
Isnani, N., & Muliyani, M. (2018a). Pengaruh Karakteristik Pasien Dengan Terjadinya Adverse Drug Reaction (ADR) Pada Pasien Diabetes Melitus Tipe 2 Rawat Inap Di Rsud Dr. H. Moch. Ansari Saleh Banjarmasin. Jurnal Mandala Pharmacon Indonesia, 4(1), 1–6.
Isnani, N., & Muliyani, M. (2018b). Studi Farmakovigilans Obat Antidiabetes Pada Pasien Rawat Jalan Diabetes Melitus Tipe Ii Di Rsud Dr. H. Moch. Ansari Saleh Banjarmasin. Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi Dan Kesehatan, 3(Vol 3, No 2 (2018)), 285–293.
Keezhipadathil, J. (2019). Evaluation of Suspected Adverse Drug Reactions of Oral Anti-diabetic Drugs in a Tertiary Care Hospital for Type II Diabetes Mellitus. Indian Journal of Pharmacy Practice, 12(2), 103–110.
Nova Hasani, Fania Putri, R. sari. (2018). Evaluation of Oral Antidiabetic Dosing and Drug Interactions in Type 2 Diabetic Patients. Evaluation of Oral Antidiabetic Dosing and Drug Interactions in Type 2 Diabetic Patients, 7(4), 191–196.
Putra, O. F. (2013). Identifikasi Adverse Drug Reactions Penggunaan Obat Antidiabetes Pada Penderita Diabetes Mellitus Di Instalasi Rawat Inap RSUD Dr. Moewardi Periode Februari …. April.
R, J., & M, B. (2018). A study to analyze the pattern, causality, severity, predictability, and preventability of adverse drug reactions among patients attending department of obstetrics and gynecology at a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 9(0), 1.
Rambitan, L. S. (2020). Article Literature Review. November, 0–6.
Sihotang, R. C., Ramadhani, R., & Tahapary, D. L. (2018). Efikasi dan Keamanan Obat Anti Diabetik Oral pada Pasien Diabetes Melitus Tipe 2 dengan Penyakit Ginjal Kronik. Jurnal Penyakit Dalam Indonesia, 5(3), 150.
Van Gaalen, R. D., Abrahamowicz, M., & Buckeridge, D. L. (2017). Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance. Drug Safety, 40(11), 1119–1129.
Yosmar, R., Putri Inanta, N., Yelly, D., & Sari, O. (2018). Studi Prospektif Adverse Drug Reactions (ADRS) Obat Hipoglikemik Oral Terhadap Pasien Diabetes Mellitus Tipe 2 di Suatu Rumah Sakit, Padang (A Prospective Study On Adverse Drug Reactions (Adrs) Of Oral Hypoglycemic Agents Among Type 2 Diabetes Patients in. Jurnal Sains Farmasi & Klinis, 5(3), 169–175.
Published
2022-10-31